Streetbeat News

Marketing

NFLX

A HarrisX survey indicates Netflix's ad-supported subscription tier is the second most popular in the U.S., suggesting over 20 million domestic subscribers. This growth signifies a successful shift towards ad revenue, with potential for further expansion as Netflix plans to eliminate the ad-free Basic plan in some markets. The survey also highlights the ad tier's role in attracting new subscribers, especially younger users, as Netflix focuses more on engagement and ad revenue in a slow-growth model.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 3:13 pm

MSFT

Microsoft has announced that its AI assistant, Copilot, is now available to all advertisers on the Microsoft Advertising Platform. This expansion comes after a period of increased testing. Copilot offers AI-powered features such as conversational chat for synthesizing information, recommendations for ad creative assets, and on-demand generation of images and other assets. These capabilities are integrated throughout the platform's UI and workflows, aiming to save advertisers time, enhance strategic decision-making, and improve performance.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 3:08 pm

RBLX

WMT

Walmart and Roblox have partnered to launch a virtual e-commerce experience within Roblox, allowing users to purchase physical goods directly in the game. This pilot test, running through May, enables users aged 13 or older in the U.S. to buy items from a virtual Walmart store and have them shipped to their real-world addresses. The initiative, which does not currently generate revenue for Roblox, aims to explore the potential of selling physical goods on the platform and could lead to Walmart expanding its e-commerce presence within Roblox.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 3:03 pm

AMZN

Amazon.com Inc (NASDAQ:AMZN) is set to report its Q1 earnings with expectations of 78 cents EPS and $133.1 billion in revenues. The stock has seen a 71.10% increase over the past year and an 18.22% YTD rise, buoyed by its strong positioning in AI, cloud computing, and e-commerce. Investors are watching AWS performance, digital advertising market-share gains, and the impact of price increases on third-party sellers. Amazon's focus on profitability, operational efficiency, and strategic investments in robotic automation are key. Technical analysis indicates a bullish trend, with a 17% upside as per Wall Street analysts.

Portfolio Pulse from Surbhi Jain

April 29, 2024 | 2:29 pm

BPTS

Biophytis SA, a clinical-stage biotech company, is implementing a strategy to find partners for its obesity drug, BIO101, currently in phase 2 development. The company aims to license out BIO101 for co-development and commercialization, targeting the high-prevalence obesity markets in the USA, China, and Brazil. Biophytis will attend the BIO US conference in San Diego to advance this strategy, emphasizing the need for collaboration to address the obesity challenge.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 1:12 pm

IMAX

IMAX and SM Cinema have expanded their partnership by agreeing to install 10 IMAX with Laser systems across the Philippines, more than doubling IMAX's presence in the growing Filipino market. This multi-theatre deal signifies a significant investment in the expansion of high-quality cinematic experiences in the region.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 12:32 pm

LPTV

RDNT

Loop Media, Inc. (LPTV) has been selected by RadNet, Inc. (RDNT) to provide ad sales services, branded channels, and customized signage for RadNet's RadNetTV Channel across its 366 imaging centers. This partnership aims to leverage Loop Media's technology and ad tech stack to deliver programmatic ad sales and personalized entertainment, enhancing RadNetTV's offerings to its viewership of over ten million annually.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 12:26 pm

NTLA

Intellia Therapeutics announced that an oral presentation from the Phase 1 portion of the ongoing NTLA-2002 Phase 1/2 study will be accepted at the European Academy of Allergy and Clinical Immunology Congress 2024. This marks a significant milestone for the company as it progresses in its clinical trials.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 11:31 am

TECH

TMO

Bio-Techne will partner with Thermo Fisher Scientific for the distribution of its products across Europe starting May 1, 2024. This agreement enables Thermo Fisher to distribute Bio-Techne's portfolio, including antibodies, proteins, and reagents, through its Fisher Scientific Channel in Europe.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 11:07 am

PFE

Pfizer Inc. (NYSE:PFE) is set to present over 50 abstracts, including 11 oral presentations, at the 2024 ASCO Annual Meeting, showcasing advances in Oncology, particularly in ADCs and bispecific antibodies. The presentations will cover Pfizer's approved and pipeline therapies across key tumor areas and core scientific modalities.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 10:47 am